Nasdaq Ontx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ontx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ontx Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Onconova Therapeutics (NASDAQ:ONTX)

Analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance Onconova Therapeutics has a 1-year low of $0.55 and a 1-year high of $1.45. The company […] ....

United States , Onconova Therapeutics Inc , Onconova Therapeutics , Get Free Report , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Stock Performance Onconova Therapeutics has a fifty-two week low of $0.55 and a fifty-two week high of $1.45. The stock has a […] ....

United States , Onconova Therapeutics Inc , Onconova Therapeutics , Free Report , Get Free Report , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Onconova Therapeutics (NASDAQ:ONTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The firm has a 50 day simple moving average of $0.82 and a 200 day simple moving average of $0.74. […] ....

United States , Millennium Management , Renaissance Technologies , Onconova Therapeutics Inc , Beacon Pointe Advisors , Vanguard Group Inc , Onconova Therapeutics , Free Report , Pointe Advisors , Vanguard Group , Get Free Report , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Onconova Therapeutics (NASDAQ:ONTX) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The stock has a market cap of $20.90 million, a PE ratio of -1.09 and a […] ....

United States , Millennium Management , Onconova Therapeutics Company Profile , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Vanguard Group Inc , Onconova Therapeutics , Get Free Report , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Trading Down 1.0 % Shares of ONTX opened at $1.00 on Friday. Onconova Therapeutics has a twelve month low of […] ....

United States , Onconova Therapeutics Company Profile , Vanguard Group Inc , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Millennium Management , Onconova Therapeutics , Get Free Report , Therapeutics Trading Down , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Initiated Coverage , Stocknews Com ,